Company / Share Buybacks
Zimmer Biomet Share Buybacks History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$487.0M
FY2025
5-year range
$126.4M / $868.0M
FY2021-FY2025
Trend
-43.9%
vs FY2024
Sector context
#26 of 101
Health Care
What the data says
At $487M, Zimmer Biomet's share buybacks ranks #26 of 101 in the Health Care sector. Share Buybacks has fluctuated over the past 6 years, ranging from $126M in FY2022 to $868M in FY2024.
Based on SEC 10-K filings.
$487M in FY2025 with a 3-year CAGR of +56.8%. Top quartile in the Health Care sector.
Declined from $692M to $487M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- +56.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#26 of 101 in Health CareTop 26% of 101This company $487.0M Sector average $570.7M
▼
-14.7% below sector average
Key checks
Key Insights
- 3-year CAGR of +56.8%, indicating consistent growth.
- In FY2025, share buybacks decreased 43.9% year-over-year.
- Ranks #26 out of 101 companies in the Health Care sector.
- Peak share buybacks was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $487.0M | -43.9% |
| FY2024 | $868.0M | +25.4% |
| FY2023 | $692.2M | +447.6% |
| FY2022 | $126.4M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $415.5M | - |
| FY2017 | - | - |
| FY2016 | $400.9M | +167.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026